Clinical Trial Update: A Controlled Study to Assess the Efficacy, Safety and Tolerability of Oral DFD-29 Extended Release Capsules [Phase 2]

View source ↗

Summary

Phase 2 trial assessing efficacy, safety, and tolerability of oral DFD-29 extended release capsules in rosacea has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rosacea

Drugs mentioned

• DFD-29 Extended Release Capsules (DFD-29)

Snippet

Sponsor: Dr. Reddy's Laboratories Limited | Conditions: Rosacea | Phase 2 | Status: COMPLETED | Results posted: 2020-04-21